Fremanezumab shows early and sustained efficacy in patients with multiple migraine treatment failuresApril 18, 2023Headache & Migraine
Ultrasound-guided stellate ganglion blockade is safe and effective in chronic migraineApril 18, 2023Headache & Migraine
CGRP monoclonal antibodies effective in preventing vestibular migraineApril 18, 2023Headache & Migraine
CGRP mAb improve migraine days throughout the menstrual cycle in real-world settingApril 18, 2023Headache & Migraine
Pre-pregnancy migraine: A potential risk factor for hypertensive disorders of pregnancyApril 18, 2023Headache & Migraine
Galcanezumab shows wearing-off effects but only in patients with chronic migraineApril 18, 2023Headache & Migraine
Meta-analysis compares efficacy of lasmiditan, rimegepant, and ubrogepant for acute treatment of migraineMarch 30, 2023Headache & Migraine
Real-world study compares benefits for patients with migraine of mAb against CGRP and its receptorMarch 30, 2023Headache & Migraine
Fremanezumab shows favorable benefit-risk profile in difficult-to-treat migraineMarch 30, 2023Headache & Migraine
Migraine: Identifying clinical traits of super-responders vs non-responders to CGRP-R mAbMarch 30, 2023Headache & Migraine
